Company / Return on Assets (ROA)
Aquestive Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-52.2%
FY2025
5-year range
-95.3% / -13.7%
FY2021-FY2025
Trend
-20.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -105.4% in FY2020 to -10.3% in FY2018.
Based on SEC 10-K filings.
-52.2% in FY2025 with a 5-year CAGR of +53.1%.
Declined from -13.7% to -52.2% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +43.1pp
- 5-Year Change
- +53.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 20.0% year-over-year.
- Peak return on assets (roa) was recorded in FY2018.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -52.2% | -20.0% |
| FY2024 | -43.5% | -217.4% |
| FY2023 | -13.7% | +85.6% |
| FY2022 | -95.3% | -6.0% |
| FY2021 | -90.0% | +14.6% |
| FY2020 | -105.4% | -34.7% |
| FY2019 | -78.2% | -659.3% |
| FY2018 | -10.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026